Skip to main content


Trump eyeing 'disruptive' changes to drug pricing, Azar says

By Bloomberg  
   September 12, 2018

The Trump administration is looking to make “disruptive” changes to U.S. drug pricing to bring down costs for patients, Health and Human Services Secretary Alex Azar said. “Every player in the system has their share of blame,” Azar said in an interview at Bloomberg headquarters in New York on Wednesday, adding that he’s working on overhauling the system. “Part of that is going to be some fairly large, disruptive changing of the rules of the road.”

Full story

Get the latest on healthcare leadership in your inbox.